Skip to main content
Home > BC Innovations > Finance

Chronological Index of : Finance

 Current Issue
  • Figure: New Public-Private Partnerships (PPPs)

    3Q16 Public-Private Partnership Roundup Finance New Public-Private Partnerships (PPPs) Formation of new PPPs in 3Q16 dropped to its lowest level in two years, reversing an upward trend in the three previous …

    Published on 10/20/2016
  • Table: CDRD's busy year

    3Q16 Public-Private Partnership Roundup Finance CDRD's busy year In the past 12 months, the Centre for Drug Research and Development (CDRD) - Canada's national drug development and commercialization organization - …

    Published on 10/20/2016
  • Table: CDRD's pharma deals

    3Q16 Public-Private Partnership Roundup Finance CDRD's pharma deals The Centre for Drug Research and Development (CDRD) has been an active accelerator for Canadian research and has formed at least seven deals with …

    Published on 10/20/2016
  • 3Q16 Public-Private Partnership Roundup

    Highlights of public-private partnerships from 3Q16

    AZ opens up to Canadian translators; AZ takes epigenetics to the lung with U.K. research groups; Fate and MSKCC ready T cells for the shelf.

    Published on 10/20/2016
  • X-ing out resistance

    Public funding roundup 3Q16

    CARB-X to accelerate antimicrobial resistance products through pipelines; Canadian funding body responds to critics; NHLBI outlines its Strategic Vision.

    Published on 10/6/2016
  • Table: Public funding highlights

    X-ing out resistance Finance Public funding highlights Selected developments and initiatives in 3Q16 from major sources of public funding including National Institutes of Health (NIH), Biomedical Advanced Research …

    Published on 10/6/2016
  • Figure: PPP Consortia

    2Q16 Public-Private Partnership Roundup Finance PPP Consortia

    Published on 8/4/2016
  • Table: Japanese R&D collaborations

    2Q16 Public-Private Partnership Roundup Finance Japanese R&D collaborations To capitalize on Japan's basic research, the country's biopharma companies have announced at least 12 deals with public institutions since…

    Published on 8/4/2016
  • 2Q16 Public-Private Partnership Roundup

    Highlights of public-private partnerships from 2Q16

    Consortia bounce back; Alacris leads a systems biology approach to cancer modeling; GSK to launch infectious disease collaboration at Tsinghua; Chugai backs Osaka's immunology center; Boehringer teams with LDC on …

    Published on 8/4/2016
  • Table: Public funding highlights

    MRCT looks east Finance Public funding highlights Selected developments and initiatives in 2Q16 from major sources of public funding including National Institutes of Health (NIH), the U.K.'s Medical Research …

    Published on 7/28/2016
  • MRCT looks east

    Public funding roundup 2Q16

    MRCT expands its drug development reach to Shanghai; Precision Medicine Initiative opts for Mayo; A*STAR and PE create joint R&D lab; NIH's Open Science finalists.

    Published on 7/28/2016
  • Table: Catalyzing Australian translation

    It takes M2 Finance Catalyzing Australian translation In the last two years, a spate of new publicly funded initiatives have been started in Australia, focused on commercializing technologies or discoveries from …

    Published on 6/30/2016
  • It takes M2

    Two Melbourne universities set up M2 Venture Catalyst to bolster translation

    By creating M2 Venture Catalyst, Monash University and the University of Melbourne are setting up Australia's first-of-its-kind translational asset management fund.

    Published on 6/30/2016
  • Figure: Academic contribution

    Found in translation Finance Academic contribution Proportion of newcos in Europe spun out of academia from 2013 to 2015. Source: BCIQ: BioCentury Online Intelligence

    Published on 5/19/2016
  • Figure: Academic enthusiasm

    Found in translation Finance Academic enthusiasm Academic-focused VC funds in Europe, 2011-15. Funds are categorized by date closed. Sources: Company websites; press releases

    Published on 5/19/2016
  • Figure: Distillery Items 2015

    Found in translation Finance Distillery Items 2015

    Published on 5/19/2016
  • Figure: Distillery Items By Country

    Found in translation Finance Distillery Items By Country Source: BioCentury Archives

    Published on 5/19/2016
  • Figure: Seed and series A funding in Europe

    Found in translation Finance Seed and series A funding in Europe Seed and series A funding received by European companies, 2012-15. Source: BCIQ: BioCentury Online Intelligence

    Published on 5/19/2016
  • Table: Accelerating translation

    Found in translation Finance Accelerating translation Translational organizations founded to commercialize science in Europe. Source: Organization websites, BioCentury Archives Organization Country Year Funding…

    Published on 5/19/2016
  • Table: Top academic spinouts

    Found in translation Finance Top academic spinouts European companies spun out of academia from 2013 to 2015 with more than $20 million in seed or series A funding, that disclosed their first funding during that …

    Published on 5/19/2016
  • Table: Top European Institutes

    Found in translation Finance Top European Institutes Top 10 European institutes by global ranking based on total Distillery items published in BioCentury Innovations in 2011-15. Source: BioCentury Archives …

    Published on 5/19/2016
  • Table: Venturing into European academia

    Found in translation Finance Venturing into European academia European venture funds focused on academic innovation, 2011-15. Source: Company websites, press releases Date closed Fund Firm/company or institution…

    Published on 5/19/2016
  • Found in translation

    Venture backing and infrastructure give Europe's biotech sector a chance to grow

    New venture investment and translational infrastructure are giving Europe the opportunity to capitalize on its strong academic capabilities.

    Published on 5/19/2016
  • Table: Translational centers

    Bridging translation Finance Translational centers Select translational centers affiliated with U.S. universities. (A) Information about whether direct grants are given to projects and companies is unavailable. …

    Published on 4/28/2016
  • Public-Private Partnership Roundup

    Highlights of public-private partnerships from 1Q16

    Genome Asia 100K harnesses industry capacity to sequence 100,000 Asians across diverse ethnic groups, without public money; Ferring and Karolinska; Roche and LDC; Microlin and University of Laval.

    Published on 4/28/2016

< Previous   1  2  3  4  Next >

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993